|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hendriks LEL, Remon J, Faivre-Finn C,
Garassino MC, Heymach JV, Kerr KM, Tan DSW, Veronesi G and Reck M:
Non-small-cell lung cancer. Nat Rev Dis Primers. 10:712024.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wallace DC: Mitochondria and cancer. Nat
Rev Cancer. 12:685–698. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Z, Zhang W, Guo S, Qi G, Huang J, Gao
J, Zhao J, Kang L and Li Q: A review of advances in mitochondrial
research in cancer. Cancer Control. 31:107327482412990722024.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou ZD, Saw WT and Tan EK: Mitochondrial
CHCHD-Containing proteins: Physiologic functions and link with
neurodegenerative diseases. Mol Neurobiol. 54:5534–5546. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kee TR, Espinoza Gonzalez P, Wehinger JL,
Bukhari MZ, Ermekbaeva A, Sista A, Kotsiviras P, Liu T, Kang DE and
Woo JA: Mitochondrial CHCHD2: Disease-associated mutations,
physiological functions, and current animal models. Front Aging
Neurosci. 13:6608432021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ming R, Li X, Wang E, Wei J, Liu B, Zhou
P, Yu W, Zong S and Xiao H: The prognostic signature of head and
neck squamous cell carcinoma constructed by Immune-related
RNA-Binding proteins. Front Oncol. 12:7957812022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thomas LW, Stephen JM, Esposito C, Hoer S,
Antrobus R, Ahmed A, Al-Habib H and Ashcroft M: CHCHD4 confers
metabolic vulnerabilities to tumour cells through its control of
the mitochondrial respiratory chain. Cancer Metab. 7:22019.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao C, Xu Z, Que H, Zhang K, Wang F, Tan
R and Fan C: ASB1 inhibits prostate cancer progression by
destabilizing CHCHD3 via K48-linked ubiquitination. Am J Cancer
Res. 14:3404–3418. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei Y, Vellanki RN, Coyaud E, Ignatchenko
V, Li L, Krieger JR, Taylor P, Tong J, Pham NA, Liu G, et al:
CHCHD2 is coamplified with EGFR in NSCLC and regulates
mitochondrial function and cell migration. Mol Cancer Res.
13:1119–1129. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miao Y, Wang J, Li Q, Quan W, Wang Y, Li
C, Wu J and Mi D: Prognostic value and immunological role of PDCD1
gene in pan-cancer. Int Immunopharmacol. 89:1070802020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Goldman MJ, Craft B, Hastie M, Repecka K,
McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, et al:
Visualizing and interpreting cancer genomics data via the Xena
platform. Nat Biotechnol. 38:675–678. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu J, Lichtenberg T, Hoadley KA, Poisson
LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee
AV, et al: An integrated TCGA Pan-cancer clinical data resource to
drive High-quality survival outcome analytics. Cell.
173:400–416.e11. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Consortium GT: Human genomics. The
genotype-tissue expression (GTEx) pilot analysis: Multitissue gene
regulation in humans. Science. 348:648–660. 2015. View Article : Google Scholar
|
|
16
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang Z, Kang B, Li C, Chen T and Zhang Z:
GEPIA2: An enhanced web server for large-scale expression profiling
and interactive analysis. Nucleic Acids Res. 47:W556–W560. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chandrashekar DS, Karthikeyan SK, Korla
PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne
U, et al: UALCAN: An update to the integrated cancer data analysis
platform. Neoplasia. 25:18–27. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sjostedt E, Zhong W, Fagerberg L, Karlsson
M, Mitsios N, Adori C, Oksvold P, Edfors F, Limiszewska A, Hikmet
F, et al: An atlas of the protein-coding genes in the human, pig,
and mouse brain. Science. 367:eaay59472020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lanczky A and Gyorffy B: Web-Based
survival analysis tool tailored for medical research (KMplot):
Development and implementation. J Med Internet Res. 23:e276332021.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yoshihara K, Shahmoradgoli M, Martinez E,
Vegesna R, Kim H, Torres-Garcia W, Trevino V, Shen H, Laird PW,
Levine DA, et al: Inferring tumour purity and stromal and immune
cell admixture from expression data. Nat Commun. 4:26122013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Malta TM, Sokolov A, Gentles AJ,
Burzykowski T, Poisson L, Weinstein JN, Kaminska B, Huelsken J,
Omberg L, Gevaert O, et al: Machine learning identifies stemness
features associated with oncogenic dedifferentiation. Cell.
173:338–354.e15. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thorsson V, Gibbs DL, Brown SD, Wolf D,
Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy
JA, et al: The immune landscape of cancer. Immunity. 51:411–412.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun D, Wang J, Han Y, Dong X, Ge J, Zheng
R, Shi X, Wang B, Li Z, Ren P, et al: TISCH: A comprehensive web
resource enabling interactive single-cell transcriptome
visualization of tumor microenvironment. Nucleic Acids Res.
49:D1420–D1430. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shankavaram UT, Varma S, Kane D, Sunshine
M, Chary KK, Reinhold WC, Pommier Y and Weinstein JN: CellMiner: A
relational database and query tool for the NCI-60 cancer cell
lines. BMC Genomics. 10:2772009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Reinhold WC, Sunshine M, Liu H, Varma S,
Kohn KW, Morris J, Doroshow J and Pommier Y: CellMiner: A web-based
suite of genomic and pharmacologic tools to explore transcript and
drug patterns in the NCI-60 cell line set. Cancer Res.
72:3499–3511. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ahn M, Ali A and Seo JH: Mitochondrial
regulation in the tumor microenvironment: Targeting mitochondria
for immunotherapy. Front Immunol. 15:14538862024. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu Y, Clegg HV, Leslie PL, Di J, Tollini
LA, He Y, Kim TH, Jin A, Graves LM, Zheng J and Zhang Y: CHCHD2
inhibits apoptosis by interacting with Bcl-x L to regulate Bax
activation. Cell Death Differ. 22:1035–1046. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yao Y, Su J, Zhao L, Li R, Liu K and Wang
S: CHCHD2 promotes hepatocellular carcinoma and indicates poor
prognosis of hepatocellular carcinoma patients. J Cancer.
10:6822–6828. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma L, Zheng LH, Zhang DG and Fan ZM:
CHCHD2 decreases docetaxel sensitivity in breast cancer via
activating MMP2. Eur Rev Med Pharmacol Sci. 24:6426–6433.
2020.PubMed/NCBI
|
